Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
Summary
Third Opinion Trial Synopsis:
Scientists are doing a study to see if a new treatment for a type of blood cancer called MM is safe and works well. They are using a medicine called venetoclax along with carfilzomib and dexamethasone. They want to see if this treatment can help people who have tried other treatments before. They are now looking for more people to join the study.
Scientists are doing a study to see if a new treatment for a type of blood cancer called MM is safe and works well. They are using a medicine called venetoclax along with carfilzomib and dexamethasone. They want to see if this treatment can help people who have tried other treatments before. They are now looking for more people to join the study.
*Third Opinion AI Generated Synopsis
Trial Summary
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in participants with relapsed or refractory MM and have received 1 to 3 prior lines of therapy. Part 4 of this study is currently enrolling.
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in participants with relapsed or refractory MM and have received 1 to 3 prior lines of therapy. Part 4 of this study is currently enrolling.
Locations & Contact
Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts: